| Jude Onyia | FY2023 | ||
| Sanjay Keswani, M.D. | Chief Medical Officer Jude Onyia, Ph.D. | FY2023 | |
| Matthew C. Abernethy | Chief Financial Officer | FY2023 | |
| Kyle W. Gano, Ph.D. | Chief Executive Officer | FY2023 | |
| Eric Benevich | Chief Commercial Officer | FY2022 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.